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Abstract
Background: Research prioritisation can help identify clinically relevant questions and encourage high-
quality, patient-centred research. Delphi methodology aims to develop consensus opinion within a group
of experts, with recent Delphi projects helping to define the research agenda and funding within several
medical and surgical specialties.
Methods: All members of the Association of Upper Gastrointestinal Surgeons (AUGIS) were asked to
submit clinical research questions using an online survey (Phase 1). Two consecutive rounds of Delphi
prioritisation by multidisciplinary HPB healthcare professionals (Phase 2) were undertaken to establish a
final list of the most highly prioritised research questions. A multidisciplinary steering committee analysed
the results of each phase.
Results: Ninety-three HPB-focussed questions were identified in Phase 1, with thirty-seven questions
of sufficient priority to enter a further prioritisation round. A final group of 11 questions considered
highest priority were identified. The most highly ranked research questions related to treatment path-
ways, operative strategies and the impact of HPB procedures on quality of life, particularly for malignant
disease.
Conclusion: Expert consensus has identified research priorities within the UK HPB surgical community
over the coming years. Funding applications, to establish well-designed, high quality collaborative
research are now required to address these questions.
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Introduction
Methodological and practical difficulties present unique chal-
lenges to the surgical research community,1 with research quality
historically variable and often poor.1,2 Integration of research
and practice through a collaborative approach can often over-
come such challenges3 and enhance research impact, such as the
Dutch Pancreatic Cancer Group in hepato-pancreato-biliary
(HPB) surgery.4–6
Identifying a national consensus on research priorities pro-
vides the opportunity to increase value and reduce waste in HPB
research.7 Furthermore, the engagement of stakeholders inThis study was presented at the 21st Annual AUGIS Conference, September
2018, Edinburgh, UK.
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research encourages the development of clinically relevant
research priorities and the potential for national collaboration in
HPB research. Using structured prioritisation methods to
achieve consensus can maximise relevance, guide funding bodies
and channel resources.
The modified Delphi methodology can be utilised to produce
consensus within a group of experts by interaction to reduce in-
dividual bias. These methods have previously identified research
questions in orthopaedic8 and colorectal surgery,9 with outputs
frequently receiving pump-priming or significant funding
following identification.10–12 However, to the authors knowledge,
clinical priority setting in HPB surgery is yet to be performed.
The aim of this work is to identify a list of highly priori-
tised clinical research questions in HPB surgery using a
modified Delphi approach to guide future research and
funding bodies.
Methods
A modified Delphi approach was performed with two distinct
phases, including two rounds of prioritisation (Fig. 1) using
methodology previously described across a broad range of
medical topics.9,13,14 Throughout the process, stakeholders were
encouraged to consider prioritisation responses based on disease
Figure 1 The modified Delphi process used to prioritise research questions in hepato-pancreato-biliary surgery
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burden, clinical relevance and answerability – factors identified
as facilitators of high-impact research.15 During each round, any
incomplete questionnaires were excluded prior to analysis.
Phase one
Healthcare professionals within the AUGIS membership were
asked to submit potential research questions across upper
gastrointestinal and HPB surgery via an online survey. This was
open to both medical professionals and multidisciplinary team
members, with no limit on the number of research questions an
individual could submit. The survey was open for at least six
weeks, with at least one reminder email was sent during this
period and through social media platforms to increase engage-
ment with the process.
All submitted questions were then grouped into four cate-
gories independently (hepato-pancreato-biliary, malignant
upper gastrointestinal surgery, benign upper gastrointestinal
surgery or bariatric surgery), with any disagreements resolved by
consensus. HPB-focussed questions were then screened, with
duplicate questions removed and similar questions streamlined
following discussion by the steering group. Where questions
related to an identical clinical research problem, questions were
combined by group consensus. Where wording of questions was
altered, agreement was reached within the steering group and
care was taken not to alter the meaning of original questions
posed.
Due to the separate sub-speciality interest within clinical
practice, questions relating to the other three categories (ma-
lignant upper gastrointestinal surgery, benign upper gastroin-
testinal surgery and bariatric surgery) were each taken forward
by individually selected and speciality-orientated steering
groups.
Steering committee
The steering committee for the Delphi process contained two
surgical registrars (SK, SP), a cancer nurse specialist (LJ), patient
and public representation (HD), a medical oncologist with
specialist interest in HPB disease (AC) and three consultant HPB
surgeons (JR, EMH, MT). Representation from within the As-
sociation of Upper Gastrointestinal Surgeons (AUGIS) com-
mittee (Education, Training and Research Lead; MT) was also
present.
Phase two
The collated list of research questions was then prioritised by
attendees at the Great Britain and Ireland Hepato-Pancreato-
Biliary Association (GBIHPBA) conference, March 2018, using
printed questionnaires (Prioritisation Round 1). Healthcare
professionals with a speciality interest in HPB surgery were asked
to prioritise each individual research question based on their
own opinion using a Likert scale (1 – low priority, 3 – neutral, 5
– high priority), in accordance with similar Delphi
processes.8,9,13,14
Scores were reviewed with a ‘cut-off ’ point determined
based on mean priority score and steering group consensus to
select those questions to move through to the final round.
Heterogeneity of responses was also examined by the steering
committee to ensure ‘block’ voting was not performed. To
ensure higher-level evidence did not already exist, a literature
search of each remaining question was conducted prior to
inclusion.
A second round of prioritisation was then performed by the
GBIHPBA membership via a further online survey, with
healthcare professionals asked to prioritise each question using
the same Likert scale as the previous round. Again, respondents
were given a minimum of six weeks with reminders sent through
email and social media during this period. Results were reviewed
by the steering committee to identify a final group of highly
prioritised questions, with consensus reached by analysing the
mean priority score and proportion of high priority responses
each question received.
Results
A total of 427 research questions were produced by 140 re-
spondents, representing 48% of the membership (Fig. 2). Sub-
specialisation in HPB surgery was declared by 47 (34%). Over-
all 153 (36%) research questions were HPB-focused. A summary
of question topic in each round of the prioritisation exercise is
shown in Table 1.
After duplicated and similar questions had been combined, 93
questions were moved forward into round 2. These research
questions were prioritised by 44 respondents, representing 44%
of the conference attendees, with a further four responses
excluded due to incompleteness. Assessment of ranking hetero-
geneity excluded one further response due the possible presence
of ‘block’ ranking (only priority ranks of 1 or 5 present).
Following steering committee review, a consensus was reached
regarding a cut-off value (mean priority score of !3.0) and a
total of 37 questions were brought forward into the last round
(Supplementary Table 1).
In the final round 42 respondents prioritised these 37 ques-
tions, with three excluded due to incompleteness. Following
steering committee review of responses, a consensus was again
reached regarding cut-off value (questions receiving >50% high
priority ranking (grade 4 or 5) in combination with a mean
priority score of !3.5; and <20% low priority ranking (1 or 2);
Supplementary Table 2) to produce 11 final highly prioritised
questions (Box 1). Across the three rounds consultant repre-
sentation remained above 50% and group demographic
remained similar (Fig. 3).
Discussion
A list of 11 high priority research topics in HPB surgery have
been derived through a modified Delphi process.
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A high proportion of these topics related to malignant disease,
particularly regarding improving outcomes in pancreatic cancer
and the operative management of colorectal cancer liver metas-
tases. This is expected, particularly as they represent a high
burden of disease,16,17 significant reduction in patient’s quality of
life and potential for improvement in survival outcomes.16,18
Furthermore there is considerable debate regarding these dis-
eases if one considers the potential roles of neoadjuvant therapy
or pathways to surgery among patients with pancreatic cancer
and of two stage liver resection (Associating Liver Partition and
Portal vein Ligation for Staged hepatectomy (ALPPS) in partic-
ular). In the case of pancreatic cancer, early stage disease detec-
tion and the development of new treatment strategies have
previously been identified as priorities eight years ago.19 Progress
within these domains has since been made, however they may
remain high priorities due to difficulties in translating basic
research to bedside20 and persistent complexities within surgical
research.21
A national quality improvement programme for iatrogenic
common bile duct injury was sufficiently prioritised for
consideration in the final group of questions (Supplementary
Table 2), however nearly a quarter of respondents (24%)
ranked this question as low priority (grade 1 or 2). Due to pri-
ority rank heterogeneity and unanimous concern within the
steering committee regarding difficulties in feasibility of deliv-
ering change at a national level, this question was not included
within the final list. Thus, this Delphi process highlights areas
where further review or data is required before those areas are the
focus of study/improvement. All final round questions have been
published here for transparency and to acknowledge that a
proportion of questions are linked by topic or clinical manage-
ment algorithms. In addition, differences in patient prioritisation
may exist and as academic advances are achieved they may
develop higher priority in the coming years. The authors also
acknowledge that current ongoing studies, of which current
progress and results are unknown, may answer some of the high-
ranked questions. It is hoped this process will support any
conclusions regarding the clinical significance of their findings.
Greater representation of benign and/or complex biliary dis-
ease may have been anticipated, particularly as it represents a
Figure 2 Overview of responses during modified Delphi process
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significant disease burden and associated clinical workload.22
Biliary sub-speciality interest was well represented across each
round (data not shown) and therefore this is unlikely to explain
their absence in the final set of topics for suggested review. It is
possible that questions relating to biliary disease will be priori-
tised in the upper gastrointestinal surgery Delphi exercise run in
parallel to this study, or that bias exists within the UK system
towards cancer-based questions due to the focus on development
of cancer care centres.
Throughout the prioritisation process, clinicians have been
integral to identifying critical priorities in the surgical manage-
ment of HPB disease, avoiding potential mismatches between
those questions clinicians wish to be addressed in research and
those questions that researchers choose to investigate.7,23,24
The use of a large cohort of healthcare professionals through
the AUGIS and GBIHPBAmembership has reduced reporter bias
and set priorities using a large multi-disciplinary cohort
containing healthcare professionals representing both clinical
and academic foci. While a variety of methods have been
described to determine consensus, there is no agreement as to the
best approach.25 Therefore the ‘certain level of agreement’
method was adopted as this is the most commonly used meth-
odology in consensus-based methodology.
Low member response rates could be highlighted as a limi-
tation to this study, particularly as responses were received from
less than half the membership in each round (47.6, 33.6 and 32%
respectively). However, similar studies using Delphi methodol-
ogy have demonstrated lower response rates, with many quoting
Table 1 Question topics included in each round
Topic Submitted
in Phase 1
Collated
questions
in Round 2
voting
Highest
scores for
Round 3
voting
Final list of
prioritisation
research
questions
Total 153a 93 37 11
Cancer 49 31 17 5
Benign 21 13 3 –
Surgical
technique
19 13 3 1
Complications 13 8 1 –
Prehabilitation 9 5 2 1
Screening 8 4 2 1
Liver
transplant
3 3 2 –
Perioperative 5 3 1 –
Chronic
pancreatitis
4 2 2 1
Palliative care 4 2 – 1
Education 1 1 – –
Miscellaneous 17 8 4 1
a Overall 427 questions were produced in Phase 1, of which 153 were
hepato-pancreato-biliary (HPB) focused.
Box 1. Final group of prioritised research questions in HPB
surgery. (Note that these questions have been listed under
topic headings and do not represent rank order.)
Pancreas
1. How do you identify patients with resectable
pancreatic cancer who would benefit from neoadju-
vant chemotherapy and/or radiotherapy? Is there a
role for surgical resection in patients with pancreatic
cancer down staged by neoadjuvant chemotherapy
and/or radiotherapy? In those patients with locally
advanced disease, in whom should resection be
offered?
2. Which blood and urine markers can identify early
stage pancreatic cancer?
3. Does fast track surgery for pancreatic carcinoma
improve overall outcome in terms of reduced
morbidity and improved survival? Which patient
cohort is suitable for fast-track surgery and in whom
should biliary drainage be performed pre-
operatively?
4. What is the natural history of intraductal papillary
mucinous neoplasms? How should patients with
detected lesions be managed?
5. In patients at high risk of pancreatic cancer, either
hereditary or chronic pancreatitis, what is the
optimal radiological surveillance (modality and
frequency)?
Liver
6. In patients with colorectal cancer and synchronous
liver metastases, which patients benefit from com-
bined primary site surgery and metastasectomy?
7. Is there a role for genetic or molecular prognostic/
predictive markers in selecting patients for resection
of colorectal liver metastases? What is the role of
biological agents in colorectal liver metastases and
what prognostic markers improve outcomes?
8. For patients with bilobar colorectal liver metastases
in whom a single stage resection is not feasible,
which technique is superior with regard to oncolog-
ical outcomes and patient-reported outcomes –
ALPPS or conventional 2-stage hepatectomy with
portal venous embolization?
Cross-speciality
9. Does a prehabilitation programme, including the
optimisation of nutrition, improve outcomes of HPB
surgery?
10. What is the impact of the cancer nurse specialist on
HPB patients, their clinical and patient-reported
outcomes, and their carers?
11. How do we maximise quality of life and survival for
patients with unresectable HPB cancer?What is the
role of nutrition in this patient group?
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around 10–18%.9,14 This suggests adequate engagement in the
process and represents the largest collation of expert opinion on
HPB research priorities to date.
The use of paper questionnaires could have introduced the
potential for respondents to readily identify questions of
particular interest in block voting during Phase 2, particularly as
questions were presented in identical order. However the
assessment of rank heterogeneity identified only one response
where this may have occurred, suggesting the introduction of
bias remained limited.
This study also highlights the process of developing a national
consensus statement for HPB research priorities. The final pri-
ority list may differ from other geographical and cultural settings,
however this process could be utilised by other national and
international groups to perform further Delphi prioritisation
exercises specific to unanswered research questions prominent
within their surgical community.
Within the steering group a patient representative reviewed
questions during phase two to ensure patient relevance and
interpretation of question structure. However, exploration of
patient perceptions and validation of the final question group
with a larger cohort is required to ensure patient-centred
research is achieved.7,25 The development of clinical vignettes
through patient and public involvement may also help further
guide funding bodies, similar to the work performed by McNair
et al following the similar process performed for colorectal
surgery.26
The questions will be disseminated to funding bodies and
encourage championing of individual research questions by
AUGIS members. Meanwhile, the newly appointed AUGIS
pancreatic cancer research lead, a joint initiative with Pancreatic
Cancer UK and Pancreatic Cancer Research Fund, will provide a
platform on which such questions can be answered. It is antic-
ipated the output from the current study will set the research
agenda in HPB surgery and hope it will further encourage
contribution to planned research and collaboration between
centres over the coming years.
In summary this Delphi process has set high research priorities
in HPB surgery, which it is hoped will align research agendas and
principle users. Malignant disease was highly prioritised, relating
to treatment pathways and specific operative strategies, together
with the impact of HPB procedures on quality of life.
Acknowledgements
The HPB Delphi research steering committee would like to thank AUGIS,
GBIHPBA and, in particular, Nichola Bartlett for their support and adminis-
trative assistance throughout the Delphi process.
Funding sources
None.
Conflicts of interest
None to declare.
References
1. Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien P-A, Reeves BC
et al. (2009 Sep 26) Challenges in evaluating surgical innovation. Lancet
374:1097–1104.
2. Solomon MJ, McLeod RS. (1993 Jan) Clinical studies in surgical jour-
nals – have we improved? Dis Colon Rectum 36:43–48.
3. Barkun JS, Aronson JK, Feldman LS, Maddern GJ, Strasberg SM,
Balliol Collaboration et al. (2009 Sep 26) Evaluation and stages of sur-
gical innovations. Lancet 374:1089–1096.
4. Rijssen LB van, Koerkamp BG, Zwart MJ, Bonsing BA, Bosscha K,
Dam RM van et al. (2017 Oct 1) Nationwide prospective audit of
pancreatic surgery: design, accuracy, and outcomes of the Dutch
Pancreatic Cancer Audit. HPB 19:919–926.
5. van der Geest LGM, van Eijck CHJ, Groot Koerkamp B, Lemmens VEPP,
Busch OR, Vissers PAJ et al. (2018 Sep 6) Trends in treatment and sur-
vival of patients with nonresected, nonmetastatic pancreatic cancer: a
population-based study. Cancer Med 7:4943–4951.
6. de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P,
Daams F et al. (2019 Jan) Minimally invasive versus open distal
pancreatectomy (LEOPARD): a multicenter patient-blinded randomized
controlled trial. Ann Surg 269:2–9.
7. Chalmers I, Bracken MB, Djulbegovic B, Garattini S, Grant J,
Gülmezoglu AM et al. (2014 Jan 11) How to increase value and reduce
waste when research priorities are set. Lancet 383:156–165.
8. Eubank BH, Mohtadi NG, Lafave MR, Wiley JP, Bois AJ, Boorman RS
et al. (2016 20) Using the modified Delphi method to establish clinical
consensus for the diagnosis and treatment of patients with rotator cuff
pathology. BMC Med Res Methodol 16:56.
9. Tiernan J, Cook A, Geh I, George B, Magill L, Northover J et al. (2014
Dec) Use of a modified delphi approach to develop research priorities
for the association of coloproctology of Great Britain and Ireland.
Colorectal Dis 16:965–970.
10. Trial Detail – UK Clinical Trial Gateway [Internet].(2019) [cited 2019 Mar
2]. Available from: https://ukctg.nihr.ac.uk/trials/trial-details/trial-
details?trialNumber=ISRCTN17573805.
11. A Trial Looking at Surgery or Different Types of Radiotherapy for Rectal
Cancer (STAR-TREC) [Internet]. (2017). Cancer Research UK [cited
2019 Mar 2]. Available from: https://www.cancerresearchuk.org/about-
cancer/find-a-clinical-trial/a-trial-looking-at-surgery-or-different-types-
of-radiotherapy-for-rectal-cancer-star-trec.
Figure 3 Distribution of responder demographics through three
rounds of prioritisation by clinical grade
HPB xxxx, xxx, xxx © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
6 HPB
Please cite this article as: Knight SR et al., Use of a modified Delphi approach to develop research priorities in HPB surgery across the United Kingdom, HPB,
https://doi.org/10.1016/j.hpb.2019.03.352
12. ISRCTN – ISRCTN52352431. (2019) Does Intravenous Lidocaine Speed
up Gut Recovery after Large Bowel Surgery? [Internet]. [cited 2019 Mar
2]. Available from: http://www.isrctn.com/ISRCTN52352431?
q=&filters=conditionCategory:Digestive%20System&sort=&offset=9&
totalResults=602&page=1&pageSize=10&searchType=basic-search.
13. Stewart RJ, Caird J, Oliver K, Oliver S. (2011 Dec) Patients’ and clini-
cians’ research priorities. Health Expect 14:439–448.
14. Burt CG, Cima RR, Koltun WA, Littlejohn CE, Ricciardi R, Temple LK
et al. (2009 May) Developing a research agenda for the American So-
ciety of Colon and Rectal Surgeons: results of a delphi approach. Dis
Colon Rectum 52:898–905.
15. Burden of Disease and Research Funding [Internet]. Articles, Reports
and Web Pages.(2018) [cited 2018 Sep 14]. Available from: http://rm21.
typepad.com/blog/2012/07/burden-of-disease.html.
16. Mohammed A, Janakiram NB, Madka V, Li M, Asch AS, Rao CV. (2018)
Current challenges and opportunities for chemoprevention of pancre-
atic cancer. Curr Med Chem 25:2535–2544.
17. Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. (2018 Jan
15) Colorectal cancer liver metastases – a population-based study on
incidence, management and survival. BMC Cancer [cited 2018 Sep 14].
Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC5769309/.
18. Hackl C, Neumann P, Gerken M, Loss M, Klinkhammer-Schalke M,
Schlitt HJ. (2014 Nov 4) Treatment of colorectal liver metastases in
Germany: a ten-year population-based analysis of 5772 cases of pri-
mary colorectal adenocarcinoma. BMC Cancer 14:810.
19. Robotin MC, Jones SC, Biankin AV, Waters L, Iverson D, Gooden H
et al. (2010 May) Defining research priorities for pancreatic cancer in
Australia: results of a consensus development process. Cancer Causes
Control 21:729–736.
20. Ma Y, Wu Q, Li X, Gu X, Xu J, Yang J. (2016 Dec) Pancreatic cancer:
from bench to bedside. Ann Transl Med [cited 2018 Sep 16];4(23).
Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/
PMC5220038/.
21. McCulloch P. (2011 Jul 8) How to improve surgical research. BMJ 343:
d4121.
22. Stinton LM, Shaffer EA. (2012 Apr) Epidemiology of gallbladder disease:
cholelithiasis and cancer. Gut Liver 6:172–187.
23. Liberati A. (2011 Nov 19) Need to realign patient-oriented and com-
mercial and academic research. Lancet 378:1777–1778.
24. Tallon D, Chard J, Dieppe P. (2000 Jun 10) Relation between agendas of
the research community and the research consumer. Lancet 355:
2037–2040.
25. Stewart D, Gibson-Smith K, MacLure K, Mair A, Alonso A, Codina C
et al. (2017) A modified Delphi study to determine the level of consensus
across the European Union on the structures, processes and desired
outcomes of the management of polypharmacy in older people. PLoS
One 12:e0188348.
26. McNair AGK, Heywood N, Tiernan J, Verjee A, Bach SP, Fearnhead NS
et al. (2017 Jan) A national patient and public colorectal research
agenda: integration of consumer perspectives in bowel disease through
early consultation. Colorectal Dis 19:O75–O85.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://doi.org/10.
1016/j.hpb.2019.03.352.
HPB xxxx, xxx, xxx © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.
HPB 7
Please cite this article as: Knight SR et al., Use of a modified Delphi approach to develop research priorities in HPB surgery across the United Kingdom, HPB,
https://doi.org/10.1016/j.hpb.2019.03.352
